India Cancer Biomarkers Market Report by Profiling Technology (Omic Technologies, Imaging Technologies, Immunoassays, Cytogenetics), Biomolecule (Genetic Biomarkers, Protein Biomarkers, Glyco-Biomarkers), Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Stomach Cancer, and Others), Application (Diagnostics, Prognostics, Risk Assessment, Drug, Discovery and Development, and Others), End User (Hospitals, Academic and Research Institutions, Ambulatory Surgical Centers, Diagnostic Laboratories, and Others), and Region 2024-2032

India Cancer Biomarkers Market Report by Profiling Technology (Omic Technologies, Imaging Technologies, Immunoassays, Cytogenetics), Biomolecule (Genetic Biomarkers, Protein Biomarkers, Glyco-Biomarkers), Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Stomach Cancer, and Others), Application (Diagnostics, Prognostics, Risk Assessment, Drug, Discovery and Development, and Others), End User (Hospitals, Academic and Research Institutions, Ambulatory Surgical Centers, Diagnostic Laboratories, and Others), and Region 2024-2032

Report Format: PDF+Excel | Report ID: SR112025A21671

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   India Cancer Biomarkers Market - Introduction

    4.1    Overview
    4.2    Market Dynamics
    4.3    Industry Trends
    4.4    Competitive Intelligence
5   India Cancer Biomarkers Market Landscape
    5.1    Historical and Current Market Trends (2018-2023)
    5.2    Market Forecast (2024-2032)
6   India Cancer Biomarkers Market - Breakup by Profiling Technology
    6.1    Omic Technologies
        6.1.1 Overview 
        6.1.2 Historical and Current Market Trends (2018-2023) 
        6.1.3 Market Forecast (2024-2032) 
    6.2    Imaging Technologies
        6.2.1 Overview 
        6.2.2 Historical and Current Market Trends (2018-2023) 
        6.2.3 Market Forecast (2024-2032) 
    6.3    Immunoassays
        6.3.1 Overview 
        6.3.2 Historical and Current Market Trends (2018-2023) 
        6.3.3 Market Forecast (2024-2032) 
    6.4    Cytogenetics
        6.4.1 Overview 
        6.4.2 Historical and Current Market Trends (2018-2023) 
        6.4.3 Market Forecast (2024-2032) 
7   India Cancer Biomarkers Market - Breakup by Biomolecule
    7.1    Genetic Biomarkers
        7.1.1 Overview 
        7.1.2 Historical and Current Market Trends (2018-2023) 
        7.1.3 Market Forecast (2024-2032) 
    7.2    Protein Biomarkers
        7.2.1 Overview 
        7.2.2 Historical and Current Market Trends (2018-2023) 
        7.2.3 Market Forecast (2024-2032) 
    7.3    Glyco-Biomarkers
        7.3.1 Overview 
        7.3.2 Historical and Current Market Trends (2018-2023) 
        7.3.3 Market Forecast (2024-2032) 
8   India Cancer Biomarkers Market - Breakup by Cancer Type
    8.1    Breast Cancer
        8.1.1 Overview 
        8.1.2 Historical and Current Market Trends (2018-2023) 
        8.1.3 Market Forecast (2024-2032) 
    8.2    Lung Cancer
        8.2.1 Overview 
        8.2.2 Historical and Current Market Trends (2018-2023) 
        8.2.3 Market Forecast (2024-2032) 
    8.3    Colorectal Cancer
        8.3.1 Overview 
        8.3.2 Historical and Current Market Trends (2018-2023) 
        8.3.3 Market Forecast (2024-2032) 
    8.4    Prostate Cancer
        8.4.1 Overview 
        8.4.2 Historical and Current Market Trends (2018-2023) 
        8.4.3 Market Forecast (2024-2032) 
    8.5    Stomach Cancer
        8.5.1 Overview 
        8.5.2 Historical and Current Market Trends (2018-2023) 
        8.5.3 Market Forecast (2024-2032) 
    8.6    Others
        8.6.1 Historical and Current Market Trends (2018-2023) 
        8.6.2 Market Forecast (2024-2032) 
9   India Cancer Biomarkers Market - Breakup by Application
    9.1    Diagnostics
        9.1.1 Overview 
        9.1.2 Historical and Current Market Trends (2018-2023) 
        9.1.3 Market Forecast (2024-2032) 
    9.2    Prognostics
        9.2.1 Overview 
        9.2.2 Historical and Current Market Trends (2018-2023) 
        9.2.3 Market Forecast (2024-2032) 
    9.3    Risk Assessment
        9.3.1 Overview 
        9.3.2 Historical and Current Market Trends (2018-2023) 
        9.3.3 Market Forecast (2024-2032) 
    9.4    Drug Discovery and Development
        9.4.1 Overview 
        9.4.2 Historical and Current Market Trends (2018-2023) 
        9.4.3 Market Forecast (2024-2032) 
    9.5    Others
        9.5.1 Historical and Current Market Trends (2018-2023) 
        9.5.2 Market Forecast (2024-2032) 
10  India Cancer Biomarkers Market - Breakup by End User
    10.1    Hospitals
        10.1.1 Overview 
        10.1.2 Historical and Current Market Trends (2018-2023) 
        10.1.3 Market Forecast (2024-2032) 
    10.2    Academic and Research Institutions
        10.2.1 Overview 
        10.2.2 Historical and Current Market Trends (2018-2023) 
        10.2.3 Market Forecast (2024-2032)  
    10.3    Ambulatory Surgical Centers
        10.3.1 Overview 
        10.3.2 Historical and Current Market Trends (2018-2023) 
        10.3.3 Market Forecast (2024-2032) 
    10.4    Diagnostic Laboratories
        10.4.1 Overview 
        10.4.2 Historical and Current Market Trends (2018-2023) 
        10.4.3 Market Forecast (2024-2032) 
    10.5    Others
        10.5.1 Historical and Current Market Trends (2018-2023) 
        10.5.2 Market Forecast (2024-2032) 
11  India Cancer Biomarkers Market – Breakup by Region 
    11.1    North India
        11.1.1 Overview
        11.1.2 Historical and Current Market Trends (2018-2023)
        11.1.3 Market Breakup by Profiling Technology
        11.1.4 Market Breakup by Biomolecule
        11.1.5 Market Breakup by Cancer Type
        11.1.6 Market Breakup by Application
        11.1.7 Market Breakup by End User
        11.1.8 Key Players
        11.1.9 Market Forecast (2024-2032)
    11.2    West and Central India
        11.2.1 Overview
        11.2.2 Historical and Current Market Trends (2018-2023)
        11.2.3 Market Breakup by Profiling Technology
        11.2.4 Market Breakup by Biomolecule
        11.2.5 Market Breakup by Cancer Type
        11.2.6 Market Breakup by Application
        11.2.7 Market Breakup by End User
        11.2.8 Key Players
        11.2.9 Market Forecast (2024-2032)
    11.3    South India
        11.3.1 Overview
        11.3.2 Historical and Current Market Trends (2018-2023)
        11.3.3 Market Breakup by Profiling Technology
        11.3.4 Market Breakup by Biomolecule
        11.3.5 Market Breakup by Cancer Type
        11.3.6 Market Breakup by Application
        11.3.7 Market Breakup by End User
        11.3.8 Key Players
        11.3.9 Market Forecast (2024-2032)
    11.4    East and Northeast India
        11.4.1 Overview
        11.4.2 Historical and Current Market Trends (2018-2023)
        11.4.3 Market Breakup by Profiling Technology
        11.4.4 Market Breakup by Biomolecule
        11.4.5 Market Breakup by Cancer Type
        11.4.6 Market Breakup by Application
        11.4.7 Market Breakup by End User
        11.4.8 Key Players
        11.4.9 Market Forecast (2024-2032)
12  India Cancer Biomarkers Market – Competitive Landscape
    12.1    Overview
    12.2    Market Structure
    12.3    Market Player Positioning
    12.4    Top Winning Strategies
    12.5    Competitive Dashboard
    12.6    Company Evaluation Quadrant
13  Profiles of Key Players
    13.1    Company A 
        13.1.1 Business Overview
        13.1.2 Product Portfolio
        13.1.3 Business Strategies
        13.1.4 SWOT Analysis
        13.1.5 Major News and Events
    13.2    Company B
        13.2.1 Business Overview
        13.2.2 Product Portfolio
        13.2.3 Business Strategies
        13.2.4 SWOT Analysis
        13.2.5 Major News and Events
    13.3    Company C
        13.3.1 Business Overview
        13.3.2 Product Portfolio
        13.3.3 Business Strategies
        13.3.4 SWOT Analysis
        13.3.5 Major News and Events
    13.4    Company D 
        13.4.1 Business Overview
        13.4.2 Product Portfolio
        13.4.3 Business Strategies
        13.4.4 SWOT Analysis
        13.4.5 Major News and Events
    13.5    Company E
        13.5.1 Business Overview
        13.5.2 Product Portfolio
        13.5.3 Business Strategies
        13.5.4 SWOT Analysis
        13.5.5 Major News and Events    
    
Company names have not been provided here as this is a sample TOC. The complete list is provided in the report.

14  India Cancer Biomarkers Market - Industry Analysis
    14.1    Drivers, Restraints, and Opportunities
        14.1.1 Overview
        14.1.2 Drivers
        14.1.3 Restraints
        14.1.4 Opportunities
    14.2   Porters Five Forces Analysis
        14.2.1 Overview
        14.2.2 Bargaining Power of Buyers
        14.2.3 Bargaining Power of Suppliers
        14.2.4 Degree of Competition
        14.2.5 Threat of New Entrants
        14.2.6 Threat of Substitutes
    14.3    Value Chain Analysis
15  Appendix

India Cancer Biomarkers Market Report by Profiling Technology (Omic Technologies, Imaging Technologies, Immunoassays, Cytogenetics), Biomolecule (Genetic Biomarkers, Protein Biomarkers, Glyco-Biomarkers), Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Stomach Cancer, and Others), Application (Diagnostics, Prognostics, Risk Assessment, Drug, Discovery and Development, and Others), End User (Hospitals, Academic and Research Institutions, Ambulatory Surgical Centers, Diagnostic Laboratories, and Others), and Region 2024-2032
Purchase Options
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials